{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:01:18Z","timestamp":1791021678409,"version":"4.1.0"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["874707"],"award-info":[{"award-number":["874707"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jaut.2024.103342","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T17:45:03Z","timestamp":1733420703000},"page":"103342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["External and internal exposome as triggers of biological signalling in systemic sclerosis \u2013 A narrative synthesis"],"prefix":"10.1016","volume":"150","author":[{"given":"Lisa MF.","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Longo","family":"Sanchez-Calero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Huaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ronsmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter HM.","family":"Hoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-001X","authenticated-orcid":false,"given":"Manosij","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103342_bib1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2011.10.022","article-title":"Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?","volume":"11","author":"Costenbader","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaut.2012.05.007","article-title":"Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop","volume":"39","author":"Selmi","year":"2012","journal-title":"J. Autoimmun."},{"issue":"8 19","key":"10.1016\/j.jaut.2024.103342_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nature Reviews Nephrology 2023"},{"key":"10.1016\/j.jaut.2024.103342_bib4","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1158\/1055-9965.EPI-05-0456","article-title":"Complementing the genome with an \u201cexposome\u201d: the outstanding challenge of environmental exposure measurement in molecular epidemiology","volume":"14","author":"Wild","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jaut.2024.103342_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyr236","article-title":"The exposome: from concept to utility","volume":"41","author":"Wild","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jaut.2024.103342_bib6","author":"Miller"},{"key":"10.1016\/j.jaut.2024.103342_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaut.2024.103342_bib8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103342_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mpmed.2021.10.010","article-title":"Systemic sclerosis: clinical features and management","volume":"50","author":"Herrick","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.jaut.2024.103342_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.berh.2010.10.007","article-title":"Epidemiology of systemic sclerosis","volume":"24","author":"Nikpour","year":"2010","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib12","first-page":"204","article-title":"Gender differences in systemic sclerosis: relationship to clinical features","volume":"1","author":"Peoples","year":"2016","journal-title":"serologic status and outcomes"},{"key":"10.1016\/j.jaut.2024.103342_bib13","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/kez486","article-title":"Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study","volume":"59","author":"Jaeger","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103342_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109267","article-title":"Global, regional, and national incidence and prevalence of systemic sclerosis","volume":"248","author":"Tian","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib15","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103342_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","article-title":"Systemic sclerosis in adults. Part I: clinical features and pathogenesis","volume":"87","author":"Jerjen","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Suppl 3","key":"10.1016\/j.jaut.2024.103342_bib17","article-title":"Pulmonary complications: one of the most challenging complications of systemic sclerosis","volume":"48","author":"Wells","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103342_bib18","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van Den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib19","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.autrev.2016.07.025","article-title":"Pulmonary involvement in systemic sclerosis","volume":"15","author":"Morales-C\u00e1rdenas","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"1 14","key":"10.1016\/j.jaut.2024.103342_bib20","first-page":"1","article-title":"Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103342_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2397198320970394","article-title":"The role of ultrasound in systemic sclerosis: on the cutting edge to foster clinical and research advancement","volume":"6","author":"Hughes","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.jaut.2024.103342_bib22","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"Carwile LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib23","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2665-9913(19)30038-4","article-title":"The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological disorder","volume":"1","author":"Lescoat","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaut.2024.103342_bib24","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/rheumatology\/keu530","article-title":"Performance of the new ACR\/EULAR classification criteria for systemic sclerosis in clinical practice","volume":"54","author":"Jordan","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103342_bib25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10067-017-3576-y","article-title":"Silica-associated systemic sclerosis in 2017: 60 years after Erasmus, where do we stand?","volume":"36","author":"Lescoat","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib26","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/ajim.22518","article-title":"From the definition of silicosis at the 1930 Johannesburg conference to the blurred boundaries between pneumoconioses, sarcoidosis, and pulmonary alveolar proteinosis (PAP)","volume":"58","author":"Vincent","year":"2015","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.jaut.2024.103342_bib27","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.5152\/eurjrheum.2020.19116","article-title":"Systemic sclerosis: to subset or not to subset, that is the question","volume":"7","author":"Johnson","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.jaut.2024.103342_bib28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103342_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cotox.2017.11.009","article-title":"Environmental xenobiotic exposure and autoimmunity","volume":"10","author":"Pollard","year":"2018","journal-title":"Curr Opin Toxicol"},{"key":"10.1016\/j.jaut.2024.103342_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib32","article-title":"Relationship between occupational risk factors and severity markers of systemic sclerosis","volume":"32","author":"Magnant","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib33","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1111\/all.14202","article-title":"Silica-related diseases in the modern world","volume":"75","author":"Hoy","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2024.103342_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-016-3791-5","article-title":"Occupational exposure to silica dust and risk of lung cancer: an updated meta-analysis of epidemiological studies","volume":"16","author":"Poinen-Rughooputh","year":"2016","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.jaut.2024.103342_bib35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00420-009-0505-7","article-title":"Occupational silica exposure as a risk factor for scleroderma: a meta-analysis","volume":"83","author":"Mc Cormic","year":"2010","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.jaut.2024.103342_bib36","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10067-017-3576-y","article-title":"Silica-associated systemic sclerosis in 2017: 60 years after Erasmus, where do we stand?","volume":"36","author":"Lescoat","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib37","first-page":"209","article-title":"Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations","volume":"3","author":"Erasmus","year":"1957","journal-title":"S. Afr. J. Lab. Clin. Med."},{"key":"10.1016\/j.jaut.2024.103342_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00296-015-3412-0","article-title":"Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort","volume":"36","author":"Rocha","year":"2016","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2024.103342_bib39","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10067-018-4045-y","article-title":"High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis","volume":"37","author":"De Decker","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.semarthrit.2018.06.009","article-title":"High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: possible pathogenetic role in disease phenotypes","volume":"48","author":"Ferri","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103342_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-pharmtox-031320-111453","article-title":"Mechanisms of environment-induced autoimmunity","volume":"61","author":"Michael Pollard","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jaut.2024.103342_bib42","series-title":"Solvents, Encyclopedia of Toxicology","first-page":"356","author":"Bonventre","year":"2014"},{"key":"10.1016\/j.jaut.2024.103342_bib43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00043764-199410000-00010","article-title":"A review of recent research on health effects of human occupational exposure to organic solvents. A critical review","volume":"36","author":"Baker","year":"1994","journal-title":"J. Occup. Med."},{"key":"10.1016\/j.jaut.2024.103342_bib44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ajim.20107","article-title":"Solvent-related health effects among construction painters with decreasing exposure","volume":"46","author":"Kaukiainen","year":"2004","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.jaut.2024.103342_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajim.1098","article-title":"Meta-analysis of systemic sclerosis and exposure to solvents","volume":"40","author":"Aryal","year":"2001","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.jaut.2024.103342_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051506","article-title":"Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis","volume":"7","author":"Barrag\u00e1n-Mart\u00ednez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103342_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib50","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00296-011-2347-3","article-title":"Diffused systemic sclerosis due to occupational solvent exposure","volume":"33","author":"Alishiri","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2024.103342_bib51","article-title":"Should systemic sclerosis be recognised as an occupational disease in Switzerland?","volume":"150","author":"Schmid","year":"2020","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.jaut.2024.103342_bib52","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10067-018-4045-y","article-title":"High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis","volume":"37","author":"de Decker","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib53","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.3389\/fimmu.2019.03094","article-title":"Environmental exposures and autoimmune diseases: contribution of gut microbiome","volume":"10","author":"Khan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0962-8479(96)90069-6","article-title":"Respiratory effects of organic solvent exposure","volume":"77","author":"Schenker","year":"1996","journal-title":"Tuber. Lung Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/ar65","article-title":"Epidemiology of organic solvents and connective tissue disease","volume":"2","author":"Garabrant","year":"2000","journal-title":"Arthritis Res."},{"key":"10.1016\/j.jaut.2024.103342_bib56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1567-5769(01)00181-3","article-title":"Occupational exposures and autoimmune diseases","volume":"2","author":"Cooper","year":"2002","journal-title":"Int Immunopharmacol"},{"issue":"5 37","key":"10.1016\/j.jaut.2024.103342_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00281-015-0507-3","article-title":"Environmental risk factors of systemic sclerosis","volume":"37","author":"Marie","year":"2015","journal-title":"Seminars in Immunopathology 2015"},{"key":"10.1016\/j.jaut.2024.103342_bib58","first-page":"228","article-title":"The burden of air pollution and temperature on Raynaud's phenomenon secondary to systemic sclerosis","volume":"44","author":"Schioppo","year":"2020","journal-title":"Epidemiol. Prev."},{"key":"10.1016\/j.jaut.2024.103342_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-023-02463-w","article-title":"The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study","volume":"24","author":"Roeser","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2024.103342_bib60","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00281-015-0507-3","article-title":"Environmental risk factors of systemic sclerosis","volume":"37","author":"Marie","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2024.103342_bib61","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3899\/jrheum.090207","article-title":"Systemic sclerosis: environmental factors","volume":"36","author":"Mora","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2018.11.001","article-title":"Systemic sclerosis and exposure to heavy metals","volume":"18","author":"Marie","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2017.01.004","article-title":"Systemic sclerosis and exposure to heavy metals: a case control study of 100 patients and 300 controls","volume":"16","author":"Marie","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib64","author":"De Martinis"},{"key":"10.1016\/j.jaut.2024.103342_bib65","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard.61.10.937","article-title":"Systemic sclerosis following human cytomegalovirus infection","volume":"61","author":"Ferri","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib66","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2013-204487","article-title":"Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis","volume":"74","author":"Moinzadeh","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/05bed72c-c6f6-4685-a732-02c78e5f66c2","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"issue":"4 10","key":"10.1016\/j.jaut.2024.103342_bib68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2014.22","article-title":"Systemic sclerosis: beyond limited and diffuse subsets?","volume":"10","author":"Varga","year":"2014","journal-title":"Nature Reviews Rheumatology 2014"},{"key":"10.1016\/j.jaut.2024.103342_bib69","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/kem021","article-title":"Systemic sclerosis\u2013rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity","volume":"46","author":"Sz\u00fccs","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103342_bib70","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/art.22647","article-title":"Clinical, immunologic, and genetic features of familial systemic sclerosis","volume":"56","author":"Assassi","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103342_bib71","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/rheumatology\/31.11.783","article-title":"The evolution of a case of overlap syndrome with systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus","volume":"31","author":"Gendi","year":"1992","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.890522","article-title":"Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and developing strategies against disease development","volume":"13","author":"Choi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899372","article-title":"Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes","volume":"13","author":"Frazzei","year":"2022","journal-title":"Front. Immunol."},{"issue":"8 19","key":"10.1016\/j.jaut.2024.103342_bib74","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nature Reviews Nephrology 2023"},{"issue":"1 10","key":"10.1016\/j.jaut.2024.103342_bib75","first-page":"1","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"L\u00f3pez-Isac","year":"2019","journal-title":"Nature Communications 2019"},{"key":"10.1016\/j.jaut.2024.103342_bib76","author":"Arnett"},{"key":"10.1016\/j.jaut.2024.103342_bib77","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1073\/pnas.1906593116","article-title":"HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry","volume":"117","author":"Gourh","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2024.103342_bib78","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1001\/archderm.1987.01660330099019","article-title":"Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles","volume":"123","author":"Luderschmidt","year":"1987","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jaut.2024.103342_bib79","article-title":"Preliminary observations on ANGPT1 and ANGPT2 polymorphisms in systemic sclerosis: ANGPT2 rs2442598 and rs3739390 are associated with disease susceptibility and diffuse disease subtype","volume":"131","author":"Michalska-Jakubus","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103342_bib80","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-012-2378-4","article-title":"Circulating angiopoietin and Tie-2 levels in systemic sclerosis","volume":"33","author":"Dunne","year":"2013","journal-title":"Rheumatol. Int."},{"issue":"1 12","key":"10.1016\/j.jaut.2024.103342_bib81","first-page":"1","article-title":"Serum markers of cardiac complications in a systemic sclerosis cohort","volume":"12","author":"Tenn\u00f8e","year":"2022","journal-title":"Scientific Reports 2022"},{"key":"10.1016\/j.jaut.2024.103342_bib82","first-page":"1","article-title":"Updates on genetics in systemic sclerosis","volume":"41","author":"Ota","year":"2021","journal-title":"Inflammation and Regeneration 2021 41:1"},{"key":"10.1016\/j.jaut.2024.103342_bib83","author":"Castiblanco"},{"key":"10.1016\/j.jaut.2024.103342_bib84","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/rheumatology\/kep368","article-title":"Genetic background of systemic sclerosis: autoimmune genes take centre stage","volume":"49","author":"Allanore","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103342_bib85","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","article-title":"Systemic sclerosis: genetics and epigenetics","volume":"41","author":"Luo","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103342_bib86","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00281-015-0499-z","article-title":"Genetics of systemic sclerosis","volume":"37","author":"Bossini-Castillo","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2024.103342_bib87","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/annrheumdis-2021-219884","article-title":"Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes","volume":"80","author":"Acosta-Herrera","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm305","article-title":"Emerging patterns of genetic overlap across autoimmune disorders","volume":"4","author":"Richard-Miceli","year":"2012","journal-title":"Genome Med."},{"key":"10.1016\/j.jaut.2024.103342_bib89","author":"Jan"},{"key":"10.1016\/j.jaut.2024.103342_bib90","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2024.103342_bib91","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.csbj.2021.05.015","article-title":"The DisGeNET cytoscape app: exploring and visualizing disease genomics data","volume":"19","author":"Pi\u00f1ero","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jaut.2024.103342_bib92","doi-asserted-by":"crossref","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","article-title":"MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search","volume":"45","author":"Rappaport","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2024.103342_bib93","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2024.103342_bib94","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1148\/radiol.2017152419","article-title":"Diffuse pulmonary ossification in fibrosing interstitial lung diseases: prevalence and associations","volume":"284","author":"Egashira","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jaut.2024.103342_bib95","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/RCT.0000000000001076","article-title":"Diffuse pulmonary ossification on high-resolution computed tomography in idiopathic pulmonary fibrosis, systemic sclerosis-related interstitial lung disease, and chronic hypersensitivity pneumonitis: a comparative study","volume":"44","author":"Walkoff","year":"2020","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.jaut.2024.103342_bib96","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2024.103342_bib97","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01177","article-title":"The role of oxidative stress in the development of systemic sclerosis related vasculopathy","volume":"9","author":"Abdulle","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jaut.2024.103342_bib99","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-011-0219-1","article-title":"Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts","volume":"14","author":"Rabquer","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2024.103342_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889296","article-title":"Construction and application of polygenic risk scores in autoimmune diseases","volume":"13","author":"Khunsriraksakul","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib101","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000001845","article-title":"Polygenic risk scores and rheumatic diseases","volume":"134","author":"Brown","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jaut.2024.103342_bib102","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/annrheumdis-2020-218558","article-title":"Genomic Risk Score impact on susceptibility to systemic sclerosis","volume":"80","author":"Bossini-Castillo","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103314","article-title":"Differentially expressed genes in systemic sclerosis: towards predictive medicine with new molecular tools for clinicians","volume":"22","author":"Keret","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"3 7","key":"10.1016\/j.jaut.2024.103342_bib104","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s40674-021-00183-0","article-title":"Insights into systemic sclerosis from gene expression profiling","volume":"7","author":"Franks","year":"2021","journal-title":"Current Treatment Options in Rheumatology 2021"},{"key":"10.1016\/j.jaut.2024.103342_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101252","article-title":"Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis","volume":"96","author":"Abraham","year":"2024","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jaut.2024.103342_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14986","article-title":"Epigenetic mechanisms driving the pathogenesis of systemic lupus erythematosus, systemic sclerosis and dermatomyositis","volume":"33","author":"Zhang","year":"2024","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103342_bib107","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/25785826.2024.2360690","article-title":"Single cell analysis in systemic sclerosis \u2013 a systematic review","volume":"47","author":"Fukasawa","year":"2024","journal-title":"Immunol Med"},{"key":"10.1016\/j.jaut.2024.103342_bib108","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.39828","article-title":"Histone deacetylase 5 is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors","volume":"68","author":"Tsou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108756","article-title":"DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma","volume":"228","author":"Coit","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib110","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1073\/pnas.1813006116","article-title":"Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma","volume":"116","author":"Tsou","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2024.103342_bib111","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2013.06.006","article-title":"Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis","volume":"149","author":"Wang","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib112","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.39828","article-title":"Histone deacetylase 5 is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors","volume":"68","author":"Tsou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib113","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/diagnostics14060652","article-title":"Recent insights into the role of DNA methylation and histone modifications in systemic sclerosis: a scoping review","volume":"14","author":"Kostova","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.jaut.2024.103342_bib114","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clim.2015.03.006","article-title":"Overexpression of JMJD3 may contribute to demethylation of H3K27me3 in CD4 + T cells from patients with systemic sclerosis","volume":"161","author":"Wang","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/art.43044","article-title":"Genome-wide integrated DNA methylome and transcriptome analysis reveals a strong dysregulated myeloid component in the epigenetic landscape of Systemic Sclerosis","author":"Mart\u00ednez-L\u00f3pez","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"10 17","key":"10.1016\/j.jaut.2024.103342_bib116","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41584-021-00683-2","article-title":"Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential","volume":"17","author":"Tsou","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib117","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.2147\/IJGM.S356877","article-title":"Epigenetic modifications in the pathogenesis of systemic sclerosis","volume":"15","author":"Yu","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jaut.2024.103342_bib118","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/rheumatology\/keu155","article-title":"Epigenetics, the holy grail in the pathogenesis of systemic sclerosis","volume":"54","author":"Altorok","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103342_bib119","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00281-015-0504-6","article-title":"Epigenetics and systemic sclerosis","volume":"37","author":"Altorok","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2024.103342_bib120","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.5152\/eurjrheum.2020.19112","article-title":"Epigenetics and systemic sclerosis: an answer to disease onset and evolution?","volume":"7","author":"Ramahi","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.jaut.2024.103342_bib121","doi-asserted-by":"crossref","first-page":"D1013","DOI":"10.1093\/nar\/gky1010","article-title":"HMDD v3.0: a database for experimentally supported human microRNA-disease associations","volume":"47","author":"Huang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2024.103342_bib122","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdermsci.2010.11.007","article-title":"Circulating miR-29a levels in patients with scleroderma spectrum disorder","volume":"61","author":"Kawashita","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jaut.2024.103342_bib123","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2230.2011.04158.x","article-title":"Circulating miR-142-3p levels in patients with systemic sclerosis","volume":"37","author":"Makino","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103342_bib124","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103342_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102396","article-title":"Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy","volume":"18","author":"Henry","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101471","article-title":"Novel concepts in systemic sclerosis pathogenesis: role for miRNAs","volume":"9","author":"Szabo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaut.2024.103342_bib127","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajpath.2012.09.023","article-title":"miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin \u03b23","volume":"182","author":"Honda","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2024.103342_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810731","article-title":"Serum microRNAs in systemic sclerosis, associations with digital vasculopathy and lung involvement","volume":"23","author":"Wajda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103342_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102396","article-title":"Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy","volume":"18","author":"Henry","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102699","article-title":"Telomeres: new players in immune-mediated inflammatory diseases?","volume":"123","author":"Heba","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103342_bib131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2015.11.006","article-title":"Ageing and the telomere connection: an intimate relationship with inflammation","volume":"25","author":"Zhang","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib132","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jid.2022.09.652","article-title":"Senescent cells accumulate in systemic sclerosis skin","volume":"143","author":"Shi","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103342_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-022-00263-2","article-title":"Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis","volume":"19","author":"Usategui","year":"2022","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.jaut.2024.103342_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115589","article-title":"Contribution of telomere length to systemic sclerosis onset: a mendelian randomization study","volume":"24","author":"Rodriguez-Martin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103342_bib135","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/thoraxjnl-2020-215918","article-title":"Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis","volume":"76","author":"Liu","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jaut.2024.103342_bib136","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/annrheumdis-2020-218918","article-title":"Autoantibodies targeting telomere-associated proteins in systemic sclerosis","volume":"80","author":"Adler","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib137","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/annrheumdis-2018-214499","article-title":"Short lymphocyte, but not granulocyte, telomere length in a subset of patients with systemic sclerosis","volume":"78","author":"Lakota","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib138","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbapap.2013.03.014","article-title":"The secretome in cancer progression","volume":"1834","author":"Paltridge","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"key":"10.1016\/j.jaut.2024.103342_bib139","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.14449","article-title":"Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma","volume":"8","author":"Mustafa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2024.103342_bib140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.canlet.2016.03.046","article-title":"Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: involvement in cancer invasion and metastasis","volume":"376","author":"Cordani","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jaut.2024.103342_bib141","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1158\/1078-0432.CCR-15-2449","article-title":"Secretome signature identifies ADAM17 as novel target for radiosensitization of non-small cell lung cancer","volume":"22","author":"Sharma","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jaut.2024.103342_bib142","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/cr.2012.89","article-title":"Global secretome analysis identifies novel mediators of bone metastasis","volume":"22","author":"Blanco","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.jaut.2024.103342_bib143","series-title":"Cancer Secretomes and Their Place in Supplementing Other Hallmarks of Cancer","first-page":"409","author":"Patel","year":"2014"},{"key":"10.1016\/j.jaut.2024.103342_bib144","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1074\/mcp.M116.064261","article-title":"Proteome and secretome analysis reveals differential post-transcriptional regulation of toll-like receptor responses","volume":"16","author":"Koppenol-Raab","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jaut.2024.103342_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103881","article-title":"Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: integrated effects on microvascular reactivity","volume":"125","author":"Michalska-Jakubus","year":"2019","journal-title":"Microvasc. Res."},{"issue":"1 12","key":"10.1016\/j.jaut.2024.103342_bib146","first-page":"1","article-title":"Serum markers of cardiac complications in a systemic sclerosis cohort","volume":"12","author":"Tenn\u00f8e","year":"2022","journal-title":"Scientific Reports 2022"},{"key":"10.1016\/j.jaut.2024.103342_bib147","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-012-2378-4","article-title":"Circulating angiopoietin and Tie-2 levels in systemic sclerosis","volume":"33","author":"Dunne","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2024.103342_bib148","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/rheumatology\/kel012","article-title":"Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis","volume":"45","author":"Ogawa","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103342_bib149","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/biof.1117","article-title":"Role of interleukin-13 in fibrosis, particularly systemic sclerosis","volume":"39","author":"O'Reilly","year":"2013","journal-title":"Biofactors"},{"key":"10.1016\/j.jaut.2024.103342_bib151","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O'Reilly","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103342_bib152","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103342_bib153","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1183\/09031936.00004711","article-title":"Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis","volume":"38","author":"Tiev","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103342_bib154","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/s10165-012-0795-6","article-title":"Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study","volume":"23","author":"Hasegawa","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib155","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jfma.2012.12.007","article-title":"Chemokine MCP1\/CCL2 and RANTES\/CCL5 gene polymorphisms influence Henoch-Sch\u00f6nlein purpura susceptibility and severity","volume":"114","author":"Yu","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.jaut.2024.103342_bib156","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib157","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/2397198319870667","article-title":"Pathogenic roles of autoantibodies in systemic sclerosis: current understandings in pathogenesis","volume":"5","author":"Sen\u00e9cal","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.jaut.2024.103342_bib158","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/pmic.200401206","article-title":"Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis","volume":"5","author":"Rottoli","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jaut.2024.103342_bib159","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2008.04.019","article-title":"Autoimmunity and oxidatively modified autoantigens","volume":"7","author":"Kurien","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cbi.2017.04.013","article-title":"Proteins oxidation and autoantibodies' reactivity against hydrogen peroxide and malondialdehyde -oxidized thyroid antigens in patients' plasmas with Graves' disease and Hashimoto Thyroiditis","volume":"272","author":"Mseddi","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jaut.2024.103342_bib161","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00125-022-05812-4","article-title":"Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes","volume":"66","author":"Strollo","year":"2023","journal-title":"Diabetologia"},{"issue":"6 8","key":"10.1016\/j.jaut.2024.103342_bib162","first-page":"1","article-title":"Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis","volume":"8","author":"Fietta","year":"2006","journal-title":"Arthritis Research & Therapy 2006"},{"key":"10.1016\/j.jaut.2024.103342_bib163","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2332\/allergolint.10-OA-0176","article-title":"Proteome analysis of bronchoalveolar lavage fluid in lung fibrosis associated with systemic sclerosis","volume":"59","author":"Shirahama","year":"2010","journal-title":"Allergol. Int."},{"key":"10.1016\/j.jaut.2024.103342_bib164","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.005033","article-title":"Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays","volume":"10","author":"Carlsson","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jaut.2024.103342_bib165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4939-8570-8_17","article-title":"Application of metabolomics in lung research","volume":"1809","author":"Reisdorph","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jaut.2024.103342_bib166","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1021\/acs.jproteome.0c00179","article-title":"Metabolic disturbances in urinary and plasma samples from seven different systemic autoimmune diseases detected by HPLC-ESI-QTOF-MS","volume":"19","author":"Fern\u00e1ndez-Ochoa","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jaut.2024.103342_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78951-6","article-title":"Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease","volume":"10","author":"Meier","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103342_bib168","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/nyas.13736","article-title":"Microbial and metabolic multi-omic correlations in systemic sclerosis patients","volume":"1421","author":"Bellocchi","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2024.103342_bib169","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2024.103342_bib170","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1517\/14712598.2016.1170804","article-title":"Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases","volume":"16","author":"Monsel","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jaut.2024.103342_bib171","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201600243","article-title":"Cigarette smoke alters the secretome of lung epithelial cells","volume":"17","author":"Mossina","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.jaut.2024.103342_bib172","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01385-2017","article-title":"Inhaled diesel exhaust alters the allergen-induced bronchial secretome in humans","volume":"51","author":"Mookherjee","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103342_bib173","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/0960327118765326","article-title":"Petroleum coke exposure leads to altered secretome profiles in human lung models","volume":"37","author":"Caruso","year":"2018","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.jaut.2024.103342_bib174","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.23735","article-title":"The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis","volume":"58","author":"Guiducci","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103342_bib175","first-page":"2747","article-title":"Elevated circulatory levels of microparticles are associated to lung fibrosis and vasculopathy during systemic sclerosis","author":"Leleu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103342_bib176","author":"Nomura"},{"key":"10.1016\/j.jaut.2024.103342_bib177","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3899\/jrheum.100780","article-title":"Plasma platelet-derived microparticles in patients with connective tissue diseases","volume":"38","author":"Oyabu","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib178","author":"Iversen"},{"key":"10.1016\/j.jaut.2024.103342_bib179","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mvr.2016.11.006","article-title":"Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis","volume":"110","author":"Michalska-Jakubus","year":"2017","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jaut.2024.103342_bib180","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5114\/ada.2019.84230","article-title":"Anti-endothelial cell antibodies are associated with apoptotic endothelial microparticles, endothelial sloughing and decrease in angiogenic progenitors in systemic sclerosis","volume":"37","author":"Michalska-Jakubus","year":"2019","journal-title":"Advances in Dermatology and Allergology\/Post\u0119py Dermatologii i Alergologii"},{"issue":"1 19","key":"10.1016\/j.jaut.2024.103342_bib181","first-page":"1","article-title":"Increased serum levels of fractalkine and mobilisation of CD34+CD45\u2212 endothelial progenitor cells in systemic sclerosis","volume":"19","author":"Benyamine","year":"2017","journal-title":"Arthritis Research & Therapy 2017"},{"key":"10.1016\/j.jaut.2024.103342_bib182","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbacli.2016.11.003","article-title":"Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease","volume":"7","author":"McCarthy","year":"2017","journal-title":"BBA Clin."},{"key":"10.1016\/j.jaut.2024.103342_bib183","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.autrev.2018.01.012","article-title":"Systemic lupus erythematosus and systemic sclerosis: all roads lead to platelets","volume":"17","author":"Scherlinger","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103342_bib184","first-page":"21","article-title":"Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts","volume":"35","author":"Wermuth","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103342_bib185","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/art.38065","article-title":"Unique protein signature of circulating microparticles in systemic lupus erythematosus","volume":"65","author":"\u00d8stergaard","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103342_bib186","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","article-title":"Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis","volume":"89","author":"Chouri","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103342_bib187","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000259","article-title":"Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7\/9 imbalance","volume":"5","author":"Liu","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jaut.2024.103342_bib188","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1289\/ehp.02110s5877","article-title":"Mercury-induced autoimmunity in mice","volume":"110","author":"Nielsen","year":"2002","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jaut.2024.103342_bib189","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1289\/ehp.11782","article-title":"Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans","volume":"117","author":"Cooper","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jaut.2024.103342_bib190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/taap.1995.1179","article-title":"Trichloroethene-induced autoimmune response in female MRL +\/+ mice","volume":"134","author":"Khan","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jaut.2024.103342_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12989-021-00439-6","article-title":"Exposure to silicates and systemic autoimmune-related outcomes in rodents: a systematic review","volume":"19","author":"Janssen","year":"2022","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.jaut.2024.103342_bib192","doi-asserted-by":"crossref","first-page":"E193","DOI":"10.1097\/EE9.0000000000000193","article-title":"The EXIMIOUS project-Mapping exposure-induced immune effects: connecting the exposome and the immunome","volume":"6","author":"Ronsmans","year":"2022","journal-title":"Environmental Epidemiology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T19:43:38Z","timestamp":1737315818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124001768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":190,"alternative-id":["S0896841124001768"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103342","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External and internal exposome as triggers of biological signalling in systemic sclerosis \u2013 A narrative synthesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103342"}}